These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18760239)

  • 1. Role of oestrogen in the development of joint symptoms?
    Tan AL; Emery P
    Lancet Oncol; 2008 Sep; 9(9):817-8. PubMed ID: 18760239
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase inhibitors and arthralgia: a growing pain?
    Murphy C; Hudis CA; Dickler MN
    Oncology (Williston Park); 2008 Nov; 22(12):1424, 1426. PubMed ID: 19322950
    [No Abstract]   [Full Text] [Related]  

  • 3. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
    Din OS; Dodwell D; Wakefield RJ; Coleman RE
    Breast Cancer Res Treat; 2010 Apr; 120(3):525-38. PubMed ID: 20157776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting a grip on aromatase inhibitor-associated arthralgias.
    Hershman DL
    J Clin Oncol; 2008 Jul; 26(19):3120-1. PubMed ID: 18474872
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological therapies can relieve aromatase inhibitor-related joint symptoms in breast cancer survivors.
    Zhang Q; Tang D; Zhao H
    Am J Clin Oncol; 2010 Dec; 33(6):557-60. PubMed ID: 20124972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
    Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
    Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving tolerance of AIs: predicting risk and uncovering mechanisms of musculoskeletal toxicity.
    Gold JM; Burstein HJ
    Oncology (Williston Park); 2008 Nov; 22(12):1416, 1424. PubMed ID: 19322949
    [No Abstract]   [Full Text] [Related]  

  • 9. Aromatase inhibitor-associated arthralgias.
    Chlebowski RT
    J Clin Oncol; 2009 Oct; 27(30):4932-4. PubMed ID: 19752332
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor.
    Kuria IM; Petekkaya I; Hasanov E; Babacan T; Dizdar O; Altundag K
    J BUON; 2012; 17(4):798-9. PubMed ID: 23335547
    [No Abstract]   [Full Text] [Related]  

  • 11. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
    Gaillard S; Stearns V
    Breast Cancer Res; 2011 Mar; 13(2):205. PubMed ID: 21457526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitor-induced arthralgia: a review.
    Niravath P
    Ann Oncol; 2013 Jun; 24(6):1443-9. PubMed ID: 23471104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
    Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation.
    Felson DT; Cummings SR
    Arthritis Rheum; 2005 Sep; 52(9):2594-8. PubMed ID: 16142740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced arthralgias and myalgias].
    Okita Y; Tsuji A
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():494-8. PubMed ID: 25831810
    [No Abstract]   [Full Text] [Related]  

  • 16. Pilot study of Iyengar yoga for management of aromatase inhibitor-associated arthralgia in women with breast cancer.
    Jacobsen PB; Muchnick S; Marcus S; Amheiser P; Reiersen P; Gonzalez B; Gomez M; Jim HS; Thompson LM; Minton S; Bower J
    Psychooncology; 2015 Nov; 24(11):1578-80. PubMed ID: 25631519
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
    Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
    J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacogenomic paradigm in breast cancer treatment.
    Offit K; Robson ME
    J Clin Oncol; 2010 Nov; 28(31):4665-6. PubMed ID: 20876427
    [No Abstract]   [Full Text] [Related]  

  • 19. Aromatase inhibitor-induced joint pain: melatonin's role.
    Burk R
    Med Hypotheses; 2008 Dec; 71(6):862-7. PubMed ID: 18782656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment.
    Laroche M; Seniow M; Roché H; Ruyssen-Witrand A
    J Rheumatol; 2016 Oct; 43(10):1945-1946. PubMed ID: 27698110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.